Cargando…

Discrimination of cirrhotic nodules, dysplastic lesions and hepatocellular carcinoma by their vibrational signature

BACKGROUND: Hepatocarcinogenesis is a multistep process characterized in patients with chronic liver diseases by a spectrum of hepatic nodules that mark the progression from regenerative nodules to dysplastic lesions followed by hepatocellular carcinoma (HCC). The differential diagnosis between prec...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Chengyuan, Kaščáková, Slávka, Chiappini, Franck, Olaya, Natalia, Sandt, Christophe, Yousef, Ibraheem, Samuel, Didier, Dumas, Paul, Guettier, Catherine, Le Naour, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710034/
https://www.ncbi.nlm.nih.gov/pubmed/26754490
http://dx.doi.org/10.1186/s12967-016-0763-6
_version_ 1782409765523030016
author Peng, Chengyuan
Kaščáková, Slávka
Chiappini, Franck
Olaya, Natalia
Sandt, Christophe
Yousef, Ibraheem
Samuel, Didier
Dumas, Paul
Guettier, Catherine
Le Naour, François
author_facet Peng, Chengyuan
Kaščáková, Slávka
Chiappini, Franck
Olaya, Natalia
Sandt, Christophe
Yousef, Ibraheem
Samuel, Didier
Dumas, Paul
Guettier, Catherine
Le Naour, François
author_sort Peng, Chengyuan
collection PubMed
description BACKGROUND: Hepatocarcinogenesis is a multistep process characterized in patients with chronic liver diseases by a spectrum of hepatic nodules that mark the progression from regenerative nodules to dysplastic lesions followed by hepatocellular carcinoma (HCC). The differential diagnosis between precancerous dysplastic nodules and early HCC still represents a challenge for both radiologists and pathologists. We addressed the potential of Fourier transform-infrared (FTIR) microspectroscopy for grading cirrhotic nodules on frozen tissue sections. METHODS: The study was focused on 39 surgical specimens including normal livers (n = 11), dysplastic nodules (n = 6), early HCC (n = 1), progressed HCC on alcoholic cirrhosis (n = 10) or hepatitis C virus cirrhosis (n = 11). The use of the bright infrared source emitted by the synchrotron radiation allowed investigating the biochemical composition at the cellular level. Chemical mapping on whole tissue sections was further performed using a FTIR microscope equipped with a laboratory-based infrared source. The variance was addressed by principal component analysis. RESULTS: Profound alterations of the biochemical composition of the pathological liver were demonstrated by FTIR microspectroscopy. Indeed, dramatic changes were observed in lipids, proteins and sugars highlighting the metabolic reprogramming in carcinogenesis. Quantifiable spectral markers were characterized by calculating ratios of areas under specific bands along the infrared spectrum. These markers allowed the discrimination of cirrhotic nodules, dysplastic lesions and HCC. Finally, the spectral markers can be measured using a laboratory FTIR microscope that may be easily implemented at the hospital. CONCLUSION: Metabolic reprogramming in liver carcinogenesis can constitute a signature easily detectable using FTIR microspectroscopy for the diagnosis of precancerous and cancerous lesions. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-016-0763-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4710034
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47100342016-01-13 Discrimination of cirrhotic nodules, dysplastic lesions and hepatocellular carcinoma by their vibrational signature Peng, Chengyuan Kaščáková, Slávka Chiappini, Franck Olaya, Natalia Sandt, Christophe Yousef, Ibraheem Samuel, Didier Dumas, Paul Guettier, Catherine Le Naour, François J Transl Med Research BACKGROUND: Hepatocarcinogenesis is a multistep process characterized in patients with chronic liver diseases by a spectrum of hepatic nodules that mark the progression from regenerative nodules to dysplastic lesions followed by hepatocellular carcinoma (HCC). The differential diagnosis between precancerous dysplastic nodules and early HCC still represents a challenge for both radiologists and pathologists. We addressed the potential of Fourier transform-infrared (FTIR) microspectroscopy for grading cirrhotic nodules on frozen tissue sections. METHODS: The study was focused on 39 surgical specimens including normal livers (n = 11), dysplastic nodules (n = 6), early HCC (n = 1), progressed HCC on alcoholic cirrhosis (n = 10) or hepatitis C virus cirrhosis (n = 11). The use of the bright infrared source emitted by the synchrotron radiation allowed investigating the biochemical composition at the cellular level. Chemical mapping on whole tissue sections was further performed using a FTIR microscope equipped with a laboratory-based infrared source. The variance was addressed by principal component analysis. RESULTS: Profound alterations of the biochemical composition of the pathological liver were demonstrated by FTIR microspectroscopy. Indeed, dramatic changes were observed in lipids, proteins and sugars highlighting the metabolic reprogramming in carcinogenesis. Quantifiable spectral markers were characterized by calculating ratios of areas under specific bands along the infrared spectrum. These markers allowed the discrimination of cirrhotic nodules, dysplastic lesions and HCC. Finally, the spectral markers can be measured using a laboratory FTIR microscope that may be easily implemented at the hospital. CONCLUSION: Metabolic reprogramming in liver carcinogenesis can constitute a signature easily detectable using FTIR microspectroscopy for the diagnosis of precancerous and cancerous lesions. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-016-0763-6) contains supplementary material, which is available to authorized users. BioMed Central 2016-01-12 /pmc/articles/PMC4710034/ /pubmed/26754490 http://dx.doi.org/10.1186/s12967-016-0763-6 Text en © Peng et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Peng, Chengyuan
Kaščáková, Slávka
Chiappini, Franck
Olaya, Natalia
Sandt, Christophe
Yousef, Ibraheem
Samuel, Didier
Dumas, Paul
Guettier, Catherine
Le Naour, François
Discrimination of cirrhotic nodules, dysplastic lesions and hepatocellular carcinoma by their vibrational signature
title Discrimination of cirrhotic nodules, dysplastic lesions and hepatocellular carcinoma by their vibrational signature
title_full Discrimination of cirrhotic nodules, dysplastic lesions and hepatocellular carcinoma by their vibrational signature
title_fullStr Discrimination of cirrhotic nodules, dysplastic lesions and hepatocellular carcinoma by their vibrational signature
title_full_unstemmed Discrimination of cirrhotic nodules, dysplastic lesions and hepatocellular carcinoma by their vibrational signature
title_short Discrimination of cirrhotic nodules, dysplastic lesions and hepatocellular carcinoma by their vibrational signature
title_sort discrimination of cirrhotic nodules, dysplastic lesions and hepatocellular carcinoma by their vibrational signature
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710034/
https://www.ncbi.nlm.nih.gov/pubmed/26754490
http://dx.doi.org/10.1186/s12967-016-0763-6
work_keys_str_mv AT pengchengyuan discriminationofcirrhoticnodulesdysplasticlesionsandhepatocellularcarcinomabytheirvibrationalsignature
AT kascakovaslavka discriminationofcirrhoticnodulesdysplasticlesionsandhepatocellularcarcinomabytheirvibrationalsignature
AT chiappinifranck discriminationofcirrhoticnodulesdysplasticlesionsandhepatocellularcarcinomabytheirvibrationalsignature
AT olayanatalia discriminationofcirrhoticnodulesdysplasticlesionsandhepatocellularcarcinomabytheirvibrationalsignature
AT sandtchristophe discriminationofcirrhoticnodulesdysplasticlesionsandhepatocellularcarcinomabytheirvibrationalsignature
AT yousefibraheem discriminationofcirrhoticnodulesdysplasticlesionsandhepatocellularcarcinomabytheirvibrationalsignature
AT samueldidier discriminationofcirrhoticnodulesdysplasticlesionsandhepatocellularcarcinomabytheirvibrationalsignature
AT dumaspaul discriminationofcirrhoticnodulesdysplasticlesionsandhepatocellularcarcinomabytheirvibrationalsignature
AT guettiercatherine discriminationofcirrhoticnodulesdysplasticlesionsandhepatocellularcarcinomabytheirvibrationalsignature
AT lenaourfrancois discriminationofcirrhoticnodulesdysplasticlesionsandhepatocellularcarcinomabytheirvibrationalsignature